Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    2062512 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
2 Recruiting Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
Condition: Diabetic Macular Oedema
Interventions: Device: Navigated laser;   Device: Conventional laser
3 Active, not recruiting The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Panretinal laser photocoagulation
4 Completed Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
Condition: Diabetic Macular Edema
Interventions: Procedure: Laser photocoagulation;   Drug: Intravitreal triamcinolone;   Drug: Intravitreal bevacizumab
5 Completed Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study
Condition: Diabetic Macular Edema
Interventions: Device: Warp 10 LED Device;   Device: Near-infrared light (NIR)
6 Completed Early Treatment Diabetic Retinopathy Study (ETDRS)
Conditions: Blindness;   Diabetic Retinopathy
Interventions: Drug: Aspirin;   Procedure: Argon Laser Photocoagulation

Indicates status has not been verified in more than two years